UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice.
about
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycansProbing the Substrate Specificity of Golgi α-Mannosidase II by Use of Synthetic Oligosaccharides and a Catalytic Nucleophile MutantEvolutional and clinical implications of the epigenetic regulation of protein glycosylation.Plasma membrane domain organization regulates EGFR signaling in tumor cellsGalectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on alpha3beta1 integrin.Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration.Identification of gene markers for the prediction of allograft rejection or permanent acceptance.Hepatoprotective bioactivity of the glycoprotein, antrodan, isolated from Antrodia cinnamomea mycelia.Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cellsN-Glycans differentially regulate eosinophil and neutrophil recruitment during allergic airway inflammationSynthesis and secretion of gonadotropins including structure-function correlates.Epigenetic modifications of caveolae associated proteins in health and disease.Tumor-Associated Glycans and Immune SurveillanceEpithelial-to-Mesenchymal Transition of RPE Cells In Vitro Confers Increased β1,6-N-Glycosylation and Increased Susceptibility to Galectin-3 Binding.Two opposing roles of O-glycans in tumor metastasis.The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.Cytogenetics and gene discovery in psychiatric disorders.Galectin-3 regulates intracellular trafficking of EGFR through Alix and promotes keratinocyte migrationFunctional roles of N-glycans in cell signaling and cell adhesion in cancer.Caveolin-1 in tumor progression: the good, the bad and the ugly.Galectin-1 signaling in leukocytes requires expression of complex-type N-glycans.Metabolism, cell surface organization, and disease.Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension.The effect of galectins on leukocyte trafficking in inflammation: sweet or sour?Extracellular galectin-3 in tumor progression and metastasis.N-acetylglucosaminyltransferase III expression is regulated by cell-cell adhesion via the E-cadherin-catenin-actin complex.Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer.Specific recognition of Leishmania major poly-beta-galactosyl epitopes by galectin-9: possible implication of galectin-9 in interaction between L. major and host cells.What Have We Learned from Glycosyltransferase Knockouts in Mice?B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma.Regulation of Eosinophil Recruitment and Activation by Galectins in Allergic Asthma.Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death.Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.Human galectin-3 interacts with two anticancer drugs.Regulation of tumor progression by extracellular galectin-3.N-linked polylactosamine glycan synthesis is regulated by co-expression of β3GnT2 and GCNT2.Beta N-acetylglucosaminyltransferase V (Mgat5) deficiency reduces the depression-like phenotype in mice.Inhibition of N-acetylglucosaminyltransferase V enhances the cetuximab-induced radiosensitivity of nasopharyngeal carcinoma cells likely through EGFR N-glycan alterations.N-glycosylation of the beta-propeller domain of the integrin alpha5 subunit is essential for alpha5beta1 heterodimerization, expression on the cell surface, and its biological function.
P2860
Q24308236-E8DC9948-92C8-47E7-9139-E424C36AC93FQ27650852-4501F204-6B51-4C79-8DBB-A4813906270BQ30418119-357D8C35-63E4-4369-8B0B-6D96A492BC4CQ30480578-2F1FDCA5-3F15-4DFF-A54E-01A0629E8DF8Q30490838-8159C005-5B1B-4D53-9984-097EFCA6A9F1Q34302948-C3D777BE-BD3A-4B05-A892-2C38E512A946Q34622395-087087B2-1BC4-4E9E-8417-0042F6C99A3DQ35137263-8A21B5D2-10F5-45E8-BCBA-3E86377A5970Q35314084-26FCB382-C693-47BF-A336-FD9A966E6881Q35515844-45F8159F-A506-4D67-85E3-6FD56D631999Q35523490-8855FBEB-044A-4CD6-9D47-59C5856ED55DQ35674847-44AAD557-AC80-4418-AE2F-4F6F3F0D263FQ35890610-A9F4D93F-C4E9-418B-82DA-785B85819635Q35892475-F6D8094D-BA39-4F74-812F-0A941AFFED24Q35972468-97F59E46-84B5-4B77-A06B-6FC1F8202547Q35994096-1730679B-F44F-435C-BC43-73E31199B0A2Q36019357-23745169-5C2F-4539-81CB-717C9270885DQ36392828-D07493C1-5F9F-4A06-97CA-4924497D690CQ37168602-F977BEB4-D974-49A0-AD8A-0A8ECBCF2091Q37174457-42C95738-6A63-4755-9ECC-BCA56EF20581Q37323219-D199DC8B-E455-4B55-8A3D-60E35AD1C117Q37671886-07444D11-FD38-495C-B5F1-748B2E310ED4Q37707674-F8881D7F-6097-45C8-AF74-9C815AA7A7C6Q37976826-07A12063-3901-4A70-BE21-B2202F430A1EQ38225141-8FEA84EF-CBEC-4371-9E06-DF379FF98A31Q38288410-FD08522E-F2B2-4935-BCD0-E4FA1963002EQ38315227-D34FB633-73C9-4640-838A-15CCE31F0254Q38355805-E37AEAF0-58C1-4AC3-BC0C-71534386DC9AQ38796983-E7182472-F018-4545-BA85-9392051E8559Q39080654-6D3667CE-2C16-4A7A-A611-421B7329D207Q39377433-03818205-0CE6-41BA-93E7-BFA9151C824AQ40547157-901E069F-F8AD-42C0-BA76-299FA613F9C9Q41684858-BD324D85-B74F-4F5E-8A8F-FABA8C3ABA60Q43139925-B5C2F5FC-DD0A-4E53-B0C3-43B8DEF03DBEQ43164816-96726E67-4670-4A26-B0B4-F7C6B9BE328FQ43874317-83ED7304-17C0-4673-80B3-F1CB6DD9DFF1Q46990512-549AF717-C897-4A88-8BDB-2390964B6C7AQ50986017-4115E633-F166-4E94-80AE-154C3C3EA801Q51804177-357BE1A4-C78C-4C7D-9FA8-F12AD78FE626
P2860
UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
UDP-N-acetylglucosamine:alpha- ...... rase V (Mgat5) deficient mice.
@ast
UDP-N-acetylglucosamine:alpha- ...... rase V (Mgat5) deficient mice.
@en
UDP-N-acetylglucosamine:alpha- ...... rase V (Mgat5) deficient mice.
@nl
type
label
UDP-N-acetylglucosamine:alpha- ...... rase V (Mgat5) deficient mice.
@ast
UDP-N-acetylglucosamine:alpha- ...... rase V (Mgat5) deficient mice.
@en
UDP-N-acetylglucosamine:alpha- ...... rase V (Mgat5) deficient mice.
@nl
prefLabel
UDP-N-acetylglucosamine:alpha- ...... rase V (Mgat5) deficient mice.
@ast
UDP-N-acetylglucosamine:alpha- ...... rase V (Mgat5) deficient mice.
@en
UDP-N-acetylglucosamine:alpha- ...... rase V (Mgat5) deficient mice.
@nl
P2093
P1476
UDP-N-acetylglucosamine:alpha- ...... rase V (Mgat5) deficient mice.
@en
P2093
Emily Partridge
James W Dennis
Judy Pawling
Michael Demetriou
Pam Cheung
P304
P356
10.1016/S0304-4165(02)00411-7
P407
P577
2002-12-01T00:00:00Z